Literature DB >> 25027946

Establishment and characterization of an experimental mouse model of allergic rhinitis.

Ming-Tse Ko1, Shun-Chen Huang, Hong-Yo Kang.   

Abstract

Allergic rhinitis (AR) is a common worldwide disease. Animal studies on AR were adopted in various investigations. However, animal studies simply aimed at establishing an animal model for AR have been seldom seen. The purpose of this study was to introduce an easy-to-establish experimental mouse model of AR. To develop a mouse model of AR, 38 Balb/c mice were randomly assigned to two groups. Mice in the study group were sensitized by intraperitoneal (IP) injection of ovalbumin (OVA) on day 1 and 6, followed by continuous inhalation (IH) of OVA solution for 1 week (day 8-14) using a newly designed inhalation box. The control group mice received sensitization of IP normal saline and IH sterilized distilled water instead of OVA. Before and after sensitization, the frequencies of nasal symptoms (sneezing, nasal rubbing) were recorded and the serum levels of total immunoglobulin E (IgE) were evaluated using ELISA. Finally, the murine nasal mucosal tissues were stained by Giemsa solution to estimate the degree of mast cell infiltration. After sensitization by IP and IH OVA, the study group showed significant phenotypic changes including increased sneezing and rubbing. Pathological and cytological findings also confirmed significant elevated serum total IgE titer and local mast cell infiltration in the study group statistically. We successfully developed a workable experimental animal model for AR that was more easily sensitized using our new-designed inhalation box, with less stress and more precisely to be observed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027946     DOI: 10.1007/s00405-014-3176-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  27 in total

1.  Structure and properties of ovalbumin.

Authors:  J A Huntington; P E Stein
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-05-25

2.  Comparison of cedar pollen-induced allergic rhinitis in passively and actively sensitized guinea pigs.

Authors:  T Nabe; N Mizutani; S Osaki; S Sugahara; H Takenaka; S Kohno
Journal:  Jpn J Pharmacol       Date:  2001-04

3.  Effect of oral immunotherapy on nasal blockage in experimental allergic rhinitis.

Authors:  Takeshi Nabe; Kayoko Kubota; Tetsuya Terada; Hiroshi Takenaka; Shigekatsu Kohno
Journal:  J Pharmacol Sci       Date:  2005-08-02       Impact factor: 3.337

4.  Cytometry in malaria: moving beyond Giemsa.

Authors:  Howard M Shapiro; Francis Mandy
Journal:  Cytometry A       Date:  2007-09       Impact factor: 4.355

5.  A mechanism of antigen-induced mucus production in nasal epithelium of sensitized rats. A comparison with lipopolysaccharide-induced mucus production.

Authors:  T Shimizu; H Hirano; Y Majima; Y Sakakura
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

6.  Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis.

Authors:  H Saito; K Howie; J Wattie; A Denburg; R Ellis; M D Inman; J A Denburg
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

7.  Physiologic assessment of allergic rhinitis in mice: role of the high-affinity IgE receptor (FcepsilonRI).

Authors:  Satoko Miyahara; Nobuaki Miyahara; Katsuyuki Takeda; Anthony Joetham; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2005-11       Impact factor: 10.793

8.  Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats.

Authors:  Manabu Kawase; Fang He; Akira Kubota; Jun-Ya Hata; Shin-Ichiro Kobayakawa; Masaru Hiramatsu
Journal:  Biosci Biotechnol Biochem       Date:  2006-12-07       Impact factor: 2.043

9.  Inverse association between T-cell immunoglobulin and mucin domain-1 and T-bet in a mouse model of allergic rhinitis.

Authors:  Geng Xu; Lei Cheng; Weiping Wen; Yun Oh; Zhonglin Mou; Jianbo Shi; Rui Xu; Huabin Li
Journal:  Laryngoscope       Date:  2007-06       Impact factor: 3.325

10.  Prolonged allergen challenge in mice leads to persistent airway remodelling.

Authors:  S J McMillan; C M Lloyd
Journal:  Clin Exp Allergy       Date:  2004-03       Impact factor: 5.018

View more
  5 in total

1.  Establishment and characterization of a multi-purpose large animal exposure chamber for investigating health effects.

Authors:  Xinze Peng; Mia R Maltz; Jon K Botthoff; Emma L Aronson; Tara M Nordgren; David D Lo; David R Cocker
Journal:  Rev Sci Instrum       Date:  2019-03       Impact factor: 1.523

2.  Effective Model of Food Allergy in Mice Sensitized with Ovalbumin and Freud's Adjuvant.

Authors:  Y Zhang; J Y Liu; J W Shao; Q Q Luo; Y Q Zhang; G Song; C Y Wang; S Y Zhao; C Wan; X H Du; L Z Xu
Journal:  Bull Exp Biol Med       Date:  2021-07-23       Impact factor: 0.804

3.  Continuous Inhalation Exposure to Fungal Allergen Particulates Induces Lung Inflammation While Reducing Innate Immune Molecule Expression in the Brainstem.

Authors:  Xinze Peng; Abdullah M Madany; Jessica C Jang; Joseph M Valdez; Zuivanna Rivas; Abigail C Burr; Yelena Y Grinberg; Tara M Nordgren; Meera G Nair; David Cocker; Monica J Carson; David D Lo
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

4.  Effect of Biospray Dressings on Eosinophil Infiltration in the Nasal Mucosa and Serum IgE Levels After Nasal Provocation in Experimental Allergic Rhinitis.

Authors:  Shan Huang; Geping Wu; Xiaodan Gu; Hongyan Zhu; Xingkai Ma; Yifang Yuan; Yan Lv; Di Li; Ling Zhang
Journal:  Allergy Rhinol (Providence)       Date:  2020-03-05

5.  Anti-Inflammatory Effects of a Cordyceps sinensis Mycelium Culture Extract (Cs-4) on Rodent Models of Allergic Rhinitis and Asthma.

Authors:  Jihang Chen; Wing Man Chan; Hoi Yan Leung; Pou Kuan Leong; Choly Tat Ming Yan; Kam Ming Ko
Journal:  Molecules       Date:  2020-09-04       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.